Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

ACT gets OK for embryonic stem cell-based trial

November 22, 2010 5:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Worcester biotech Advanced Cell Technology Inc. has received clearance from the U.S. Food and Drug Administration to launch a Phase 1/2 clinical trial using retinal cells based on human embryonic stem cells.

Gene linked to worsening kidney disease in African-Americans

November 20, 2010 4:34 pm | by EurekAlert | News | Comments

(American Society of Nephrology) In African-Americans with kidney disease related to hypertension (high blood pressure), a common gene variant is associated with a sharply increased risk of progressive kidney disease, according to a study presented at the American Society of Nephrology's...

Propoxyphene: Withdrawal - Risk of Cardiac Toxicity(2)

November 19, 2010 8:31 am | by U.S. Food & Drug Administration | News | Comments

New data shows that Propoxyphene and Propoxyphene-containing products can cause serious toxicity to the heart, even when used at therapeutic doses.

Advertisement

ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services

November 19, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Nov. 19, 2010 /PRNewswire-USNewswire/ -- ECRI Institute Patient Safety Organization (PSO) today announces an agreement to provide patient safety services to the Tennessee Center for Patient Safety established by the Tennessee Hospital Association. ECRI Institute PSO...

Boston Scientific to Acquire Sadra Medical

November 19, 2010 7:34 am | by Boston Scientific | News | Comments

Innovative percutaneous aortic valve replacement system provides entry into emerging market of structural heart disease

Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market

November 19, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food...

FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury

November 19, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events...

Solos Endoscopy, Inc. Announces Recapitalization Plan for 2011

November 19, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

BOSTON, Nov. 19, 2010 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company's management has approved its 2011 recapitalization plan in order to position itself for growth over the next twelve months. The recapitalization plan is designed to increase...

Advertisement

Lynch Syndrome Teleconference

November 19, 2010 5:36 am | by AACR | News | Comments

PHILADELPHIA — Widespread genetic testing for Lynch Syndrome appears to be a cost-effective strategy for identifying those at risk for colorectal and endometrial cancer, according to a report in Cancer Prevention Research, a journal of the American Association for Cancer Research. The...

CDRH Learn (New Courses Available in English, Spanish, and Chinese)

November 19, 2010 5:31 am | by U.S. Food & Drug Administration | News | Comments

CDRH Learn is our latest innovative educational tool. It consists of a series of training modules describing many aspects of medical device and radiological health regulation, covering both premarket and postmarket issues...

Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplasty's Urgent® PC Neuromodulation System

November 19, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Nov. 19, 2010 /- Uroplasty, Inc. (Nasdaq: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Palmetto GBA for California, Nevada and Hawaii, a regional Medicare carrier,...

Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®

November 19, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Nov. 19, 2010 /- Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and...

VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy

November 19, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

BROOMFIELD, Colo., Nov. 19, 2010 /- Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer (NSCLC) were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in...

Advertisement

Masimo to Present at Piper Jaffray 22nd Annual Healthcare Conference

November 19, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 19, 2010 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Piper Jaffray 22nd Annual Healthcare Conference at The New York Palace in New York City on Tuesday, November 30, at 12:30 p.m. ET.  A live audiocast of the...

Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition

November 19, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., Nov. 19, 2010 /- At the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 - December 2 in Chicago, Siemens Healthcare (Booth #822, East Building/Lakeside Center, Hall D) will unveil the Biograph™ mMR*, the...

Spain is leading the fight against rare anemias in Europe

November 19, 2010 2:33 am | by EurekAlert | News | Comments

(IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer) Health care professionals and patients get together for the first time in Spain against rare anemias. One percent of couples are at risk of having a newborn who suffers a severe hemoglobin syndrome. In Spain the...

Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death

November 19, 2010 1:34 am | by Boston Scientific | News | Comments

NATICK, Mass., Nov. 19, 2010 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its INCEPTA™, ENERGEN™ and PUNCTUA™ cardiac resynchronization therapy defibrillators (CRT-Ds) and impl

Inspiration Biopharmaceuticals Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A

November 18, 2010 10:35 pm | by Bio-Medicine.Org | News | Comments

LAGUNA NIGUEL, Calif., Nov. 19, 2010 /- Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced the Company has initiated treatment of patients in a pivotal clinical study of OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, for the treatment of acquired...

Businessman-philanthropist assists TGen-VARI study of rare cancer

November 18, 2010 10:33 pm | by EurekAlert | News | Comments

(The Translational Genomics Research Institute) International businessman and philanthropist Foster Friess has donated $50,000 to help launch a study of small cell carcinoma of the ovary by the Translational Genomics Research Institute and the Van Andel Research Institute.

Reports claiming ALS caused by head trauma lacks scientific validation

November 18, 2010 8:33 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A recent study suggesting that amyotrophic lateral sclerosis (ALS) may be attributed to "repetitive head trauma experienced in collision sports" lacks scientific epidemiological evidence to support this claim. In a review of the 12-patient study, several experts...

How Brain Imaging Could Help Predict Alzheimer's

November 18, 2010 7:34 pm | by Massachusetts Institute of Technology | News | Comments

The discovery could one day allow doctors to catch the disease before it's done irreversible damage.

MIT scientist wins $1.3M grant from Paul Allen foundation

November 18, 2010 2:37 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

An MIT professor and researcher has landed a million dollar-plus share of $9.4 million given out by the Paul G. Allen Family Foundation to advance neuroscience and cellular engineering research.

Modulating a protein in the brain could help control Alzheimer's disease

November 18, 2010 9:34 am | by EurekAlert | News | Comments

(Temple University) A protein known to exist in the brain for more than 30 years, called 5-lipoxygenase, has been found to play a regulatory role in the formation of the amyloid beta in the brain, the major component of plaques implicated in the development of Alzheimer's disease.

Elsevier launches HESI QuizMe nursing app series

November 18, 2010 9:34 am | by EurekAlert | News | Comments

(Elsevier) Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced that the new HESI QuizMe app series for nursing students is available from the Apple App Store. These apps familiarize nursing students with clinically based...

Reportlinker Adds Global HPLC Systems & Accessories Industry

November 18, 2010 7:40 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Nov. 18, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global HPLC Systems & Accessories Industry http://www.reportlinker.com/p090673/Global-HPLC-Systems--Accessories-Industry.html This report analyzes the worldwide...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading